Correlation Between Mydecine Innovations and Abattis Bioceuticals

Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Abattis Bioceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Abattis Bioceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mydecine Innovations Group and Abattis Bioceuticals Corp, you can compare the effects of market volatilities on Mydecine Innovations and Abattis Bioceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Abattis Bioceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Abattis Bioceuticals.

Diversification Opportunities for Mydecine Innovations and Abattis Bioceuticals

0.0

Correlation Coefficient

Mydecine Innovations  Abattis Bioceuticals

Pay attention - limited upside

The 3 months correlation between Mydecine and Abattis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Abattis Bioceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abattis Bioceuticals Corp and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Abattis Bioceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abattis Bioceuticals Corp has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Abattis Bioceuticals go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Abattis Bioceuticals

If you would invest  0.40  in Mydecine Innovations Group on December 23, 2024 and sell it today you would earn a total of  0.50  from holding Mydecine Innovations Group or generate 125.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Mydecine Innovations Group  vs.  Abattis Bioceuticals Corp

Mydecine Innovations

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Abattis Bioceuticals Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Abattis Bioceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental drivers, Abattis Bioceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Mydecine Innovations and Abattis Bioceuticals

The main advantage of trading using opposite Mydecine Innovations and Abattis Bioceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Abattis Bioceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abattis Bioceuticals will offset losses from the drop in Abattis Bioceuticals' long position.

The idea behind Mydecine Innovations Group and Abattis Bioceuticals Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.